Pharmacological modulation of procoagulant microparticles improves haemodynamic dysfunction during septic shock in rats

被引:25
作者
Boisrame-Helms, Julie [1 ,2 ]
Delabranche, Xavier [1 ,2 ]
Degirmenci, Su-Emmanuelle [2 ]
Zobairi, Fatiha [3 ]
Berger, Asael [1 ,2 ]
Meyer, Gregory [4 ]
Burban, Melanie [4 ]
Mostefai, Hadj-Ahmed [1 ]
Levy, Bruno [5 ]
Toti, Florence [3 ,4 ]
Meziani, Ferhat [1 ,2 ]
机构
[1] Hop Univ Strasbourg, Nouvel Hop Civil, Serv Reanimat Med, Strasbourg, France
[2] Univ Strasbourg, Fac Med, EA Federat Med Translat Strasbourg FMTS 3072, Strasbourg, France
[3] Univ Strasbourg, Fac Med, EA Stress Vasc & Tissulaire Transplantat 7293, Strasbourg, France
[4] Univ Strasbourg, Fac Pharm, Lab Biophoton & Pharmacol, UMR 7213,CNRS, Illkirch Graffenstaden, France
[5] Univ Nancy, Fac Med, Equipe AVENIR Inserm, Grp CHOC, Nancy, France
关键词
Activated protein C; haemodynamic dysfunction; inflammation; microparticles; septic shock; PROTEIN-C RECEPTOR; CIRCULATING MICROPARTICLES; PLATELET MICROPARTICLES; ENDOTHELIAL DYSFUNCTION; ORGAN DYSFUNCTION; BIASED AGONISM; SEVERE SEPSIS; COAGULATION; THROMBIN; ANTICOAGULANT;
D O I
10.1160/TH13-04-0313
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Circulating microparticles play a pro-inflammatory and procoagulant detrimental role in the vascular dysfunction of septic shock. It was the objective of this study to investigate mechanisms by which a pharmacological modulation of microparticles could affect vascular dysfunction in a rat model of septic shock. Septic or sham rats were treated by activated protein C (aPC) and resuscitated during 4 hours. Their microparticles were harvested and inoculated to another set of healthy recipient rats. Haemodynamic parameters were monitored, circulating total procoagulant microparticles assessed by prothrombinase assay,, and their cell origin characterised. Mesenteric resistance arteries,; aorta and heart were harvested for western blotting analysis. We found that a) the amount and phenotype of circulating microparticles were altered in septic rats with an enhanced endothelial, leucocyte and platelet contribution; b) aPC treatment significantly reduced the generation of leucocyte microparticles and norepinephrine requirements to reach the mean arterial pressure target in septic rats; c) Microparticles from untreated septic rats, but not from aPC-treated ones, significantly reduced the healthy recipients' mean arterial pressure; d) Microparticle thromboxane content and aPC activity were significantly increased in aPC-treated septic rats. In inoculated naive recipients, microparticles from aPC-treated septic rats prompted reduced NF-kappa B and cyclooxygenase-2 arterial activation, blunted the generation of pro-inflammatory iNOS and secondarily increased platelet and endothelial microparticles. In conclusion, in this septic shock model, increased circulating levels of procoagulant microparticles led, to negative haemodynamic outcomes. Pharmacological treatment by aPC modified the cell origin and levels of circulating microparticles, thereby limiting vascular inflammation and favouring haemodynamic improvement.
引用
收藏
页码:154 / 164
页数:11
相关论文
共 46 条
  • [1] Septic shock
    Annane, D
    Bellissant, E
    Cavaillon, JM
    [J]. LANCET, 2005, 365 (9453) : 63 - 78
  • [2] Lipid raft localization regulates the cleavage specificity of protease activated receptor 1 in endothelial cells
    Bae, J. -S.
    Yang, L.
    Rezaie, A. R.
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2008, 6 (06) : 954 - 961
  • [3] Arachidonic acid in platelet microparticles up-regulates cyclooxygenase-2-dependent prostaglandin formation via a protein kinase C mitogen-activated protein kinase-dependent pathway
    Barry, OP
    Kazanietz, MG
    Praticò, D
    FitzGerald, GA
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (11) : 7545 - 7556
  • [4] Berckmans RJ, 2001, THROMB HAEMOSTASIS, V85, P639
  • [5] Bhattacharya A, 2000, J PHARMACOL EXP THER, V295, P284
  • [6] Boisramé-Helms J, 2013, CURR VASC PHARMACOL, V11, P150
  • [7] Circulating microparticles from patients with myocardial infarction cause endothelial dysfunction
    Boulanger, CM
    Scoazec, A
    Ebrahimian, T
    Henry, P
    Mathieu, E
    Tedgui, A
    Mallat, Z
    [J]. CIRCULATION, 2001, 104 (22) : 2649 - 2652
  • [8] Mechanisms of anticoagulant and cytoprotective actions of the protein C pathway
    Bouwens, E. A. M.
    Stavenuiter, F.
    Mosnier, L. O.
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 242 - 253
  • [9] Endothelium-derived microparticles impair endothelial function in vitro
    Brodsky, SV
    Zhang, F
    Nasjletti, A
    Goligorsky, MS
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2004, 286 (05): : H1910 - H1915
  • [10] Delabranche X, 2013, INTENSIVE CARE MED